Nadrion Trademark Details

Nadrion was registered on Tuesday, July 12, 2005 and is currently owned by Pfizer Inc. under the registration number 2967526 . This mark is dead with a status of Cancelled - Section 8. The last case file activity for this mark occured 8 years ago on Friday, February 19, 2016, according to the United State Patent & Trademark Office

Word Mark	Nadrion
Status	Dead Registered 710 — Cancelled - Section 8

Pfizer Inc.
235 East 42nd Street
New York, Ny 10017

Serial Number	76327944
Registration Number	2967526
Status Date	Friday, February 19, 2016
Filing Date	Friday, February 19, 2016
Registration Date	Tuesday, July 12, 2005
Attorney	Tiffany Trunko

Correspondent

TIFFANY TRUNKO08
PFIZER INC.
150 E 42ND ST, 6TH FLOOR
NEW YORK NY 10017-5612

Case File Statements

Certificate of Correction for Registration	In the statement, column 1, lines 4 through 14 should be deleted. In the statement, column 2, lines 1 through 7 should be deleted, and "PHARMACEUTICAL PREPARATIONS FOR THE TREATMENT OF CARDIOVASCULAR DISEASE, HYPERTENSION" should be inserted.
Goods & Services	Pharmaceutical Preparations for the Treatment of Cardiovascular Disease , [ Central Nervous System Diseases and Disorders, Neurological Disorders, Urological Disorders, Gastrointestinal Disorders, Musculoskeletal Disorders, Allergies, Diabetes, ] Hypertension, [ Erectile Dysfunction, Sexual Dysfunction, Stroke, Cancer, Migraines, Pain, Obesity, Inflammation and Inflammatory Diseases, Respiratory and Infectious Diseases, and Immunological, Bacterial, Viral and Fungal Disorders; Pharmaceutical Preparations, Namely, Cholesterol Preparations, Smoking Cessation Preparations, Tissue and Skin Repair Preparations, Dermatological Preparations, and Gynecological Preparations ]

In the statement, column 1, lines 4 through 14 should be deleted. In the statement, column 2, lines 1 through 7 should be deleted, and "PHARMACEUTICAL PREPARATIONS FOR THE TREATMENT OF CARDIOVASCULAR DISEASE, HYPERTENSION" should be inserted.

Pharmaceutical Preparations for the Treatment of Cardiovascular Disease , [ Central Nervous System Diseases and Disorders, Neurological Disorders, Urological Disorders, Gastrointestinal Disorders, Musculoskeletal Disorders, Allergies, Diabetes, ] Hypertension, [ Erectile Dysfunction, Sexual Dysfunction, Stroke, Cancer, Migraines, Pain, Obesity, Inflammation and Inflammatory Diseases, Respiratory and Infectious Diseases, and Immunological, Bacterial, Viral and Fungal Disorders; Pharmaceutical Preparations, Namely, Cholesterol Preparations, Smoking Cessation Preparations, Tissue and Skin Repair Preparations, Dermatological Preparations, and Gynecological Preparations ]

Classifications

International Class Codes	005 — Class 5 includes mainly pharmaceuticals and other preparations for medical or veterinary purposes.
U.S. Class Codes	006, 018, 044, 046, 051, 052
Status	2 — Sec. 8 – Entire Registration
Status Date	Friday, February 19, 2016
First Use Anywhere	Thursday, February 17, 2005
First Use In Commerce	Thursday, February 17, 2005
Primary Code	005

Trademark Timeline

Oct 19 2001

Trademark application filed with USPTO
Dec 28 2001

Assigned To Examiner
Dec 31 2001

Non-Final Action Mailed
Jun 25 2002

Correspondence Received In Law Office
Jun 25 2002

Paper Received
Aug 12 2002

Approved For Pub - Principal Register
Oct 09 2002

Notice of Publication
Oct 29 2002

Published For Opposition
Jan 21 2003

Noa Mailed - Sou Required From Applicant
Jul 09 2003

Extension 1 Filed
Jul 09 2003

Teas Extension Received
Jul 11 2003

Extension 1 Granted
Jan 06 2004

Extension 2 Filed
Jan 06 2004

Teas Extension Received
Jan 29 2004

Extension 2 Granted
Apr 26 2004

Assigned To Examiner
Jul 12 2004

Extension 3 Filed
Jul 12 2004

Teas Extension Received
Jul 21 2004

Case File In Ticrs
Aug 05 2004

Extension 3 Granted
Jan 13 2005

Extension 4 Filed
Jan 13 2005

Teas Extension Received
Feb 02 2005

Extension 4 Granted
Feb 17 2005

First use anywhere for the mark
Feb 17 2005

First use in commerce for the mark
Mar 14 2005

Use Amendment Filed
Mar 14 2005

Extension 5 Filed
Mar 15 2005

Teas Statement of Use Received
Mar 15 2005

Teas Extension Received
Apr 08 2005

Extension 5 Granted
Apr 13 2005

Statement of Use Processing Complete
Apr 15 2005

Allowed Principal Register - Sou Accepted
Apr 22 2005

Assigned To Lie
Apr 26 2005

Law Office Registration Review Completed
Jul 12 2005

Registered-Principal Register
Jul 12 2005

Trademark officially registered with the USPTO
Aug 01 2005

Sec 7 Request Filed
Aug 01 2005

Paper Received
Nov 09 2005

Certificate of Correction Issued
Mar 17 2006

Assigned To Paralegal
Mar 20 2006

Post Registration Action Mailed No Response Required
Feb 19 2016

Cancelled Sec. 8 (10-Yr)/expired Section 9

Nadrion Trademark Details

Correspondent

Case File Statements

Classifications

Trademark Timeline

You must be signed in to print.

Once signed in, look for the PDF button.